Welcome to our dedicated page for Skinhealth Systems news (Ticker: SKIN), a resource for investors and traders seeking the latest updates and insights on Skinhealth Systems stock.
SkinHealth Systems Inc. reports developments tied to its global medical aesthetics business, with recurring updates on financial results, margin performance, adjusted EBITDA, installed-base activity and its recurring consumables model. The company, formerly The Beauty Health Company, trades on the Nasdaq Capital Market under the symbol SKIN.
Company news also covers the Hydrafacial platform, SkinStylus microneedling and nano-channeling treatments, HydraScalp with Keravive, provider adoption, consumer skin-health research, board appointments and the completed corporate rebrand to SkinHealth Systems.
The Beauty Health Company (NASDAQ: SKIN) reported third-quarter net sales of $88.8 million, marking a 30% year-over-year growth and exceeding expectations for the seventh consecutive quarter. The company raised its fiscal 2022 net sales guidance to $360-$365 million. Adjusted EBITDA for the quarter was $16.5 million, up from $5.8 million in Q3 2021. However, it revised its full-year adjusted EBITDA guidance down to $45-$50 million due to macroeconomic pressures, including foreign exchange impacts and China's zero-COVID policy.
The Beauty Health Company (NASDAQ:SKIN) has announced a partnership with Dr. Dennis Gross Skincare to develop a new booster for Hydrafacial treatments. This collaboration aims to blend Dr. Gross’s skincare technology with Hydrafacial’s Vortex Fusion technology, enhancing treatment customization. The new booster is expected to be available in 2023 and is part of a broader strategy to quickly respond to consumer trends. BeautyHealth CEO Andrew Stanleick highlighted the innovative nature of their booster strategy, positioning it as a key differentiator in the beauty industry.
The Beauty Health Company (NASDAQ:SKIN) announced the launch of a new exfoliating product, the Glytone AHA Resurfacing Cellular Booster, co-created with Glytone. This new booster will be available at U.S. providers starting November 9. It features three alpha hydroxy acids designed to enhance skin texture and achieve a radiant complexion. The product is compatible with Hydrafacial’s patented technology, targeting consumers with sensitive skin. The collaboration emphasizes both brands' commitment to dermatological science and personalized skincare solutions.
Beauty Health Company (NASDAQ: SKIN) has appointed David Aquino as Executive Vice President, Global Operations. This new role is crucial for enhancing the company's global supply chain, quality, distribution, and logistics. David's expertise, particularly from his time at Kindthread and SharkNinja, is expected to accelerate BeautyHealth's growth phase. The company aims to optimize infrastructure to capitalize on opportunities in the beauty health market. This appointment aligns with their strategy to double business size and triple adjusted EBITDA by 2025.
The Beauty Health Company (NASDAQ:SKIN) will report its third quarter 2022 financial results before market open on November 8, 2022. Following this, an investor conference call will take place at 8:30 a.m. Eastern Time. Investors and analysts can access the call via webcast. The company, known for its Hydrafacial brand, continues to expand its presence globally with nearly 23,000 delivery systems operational in over 90 countries.
The BeautyHealth Company (NASDAQ:SKIN) has launched the Hydrafacial x JLo Beauty Booster, a new treatment available nationwide. This collaboration, the first celebrity partnership for Hydrafacial, sold out on its first day of presales. The booster, inspired by JLo Beauty's popular serum, uses a proprietary formula featuring Olive Leaf Extract and Niacinamide. This partnership allows JLo Beauty to expand into the professional skincare market, while Hydrafacial enhances its offerings to clients. The product was developed in under six months and joins a broader lineup of Hydrafacial boosters.
The Beauty Health Company (NASDAQ: SKIN) has authorized a $200 million share repurchase program to enhance shareholder value. They have initiated an accelerated share repurchase (ASR) agreement with JPMorgan Chase Bank for $100 million, which is expected to conclude in Q1 2023. Approximately 7.7 million shares will be acquired initially, signaling management's confidence in the company's growth potential and disciplined capital allocation. The remaining $100 million will be available for future repurchase activities based on market conditions.
The Beauty Health Company (NASDAQ: SKIN) hosted its Analyst and Investor Day in New York City, unveiling a strategy to double net sales and triple adjusted EBITDA by 2025. The company aims for net sales between $600-$700 million, translating to a CAGR of 20%-27%. With only 5% market penetration globally, BeautyHealth cites significant growth potential, particularly in EMEA and APAC. The event emphasized the company's innovative Hydrafacial technology and plans to enhance consumer engagement through education and marketing.
The Beauty Health Company (NASDAQ:SKIN) has partnered with Organicell to develop a groundbreaking exosome booster targeting aging and inflammation. This innovative product will utilize Organicell's advanced exosome technology, harnessing over 300 cytokines and growth factors. With a rapid development process, the booster is expected to enhance Hydrafacial's offerings and will launch in early 2024. This collaboration capitalizes on co-creation, allowing the company to stay ahead in the skincare market by responding quickly to consumer demands for regenerative treatments.
The Beauty Health Company (NASDAQ:SKIN) has launched Hydrafacial Experience Centers in Paris and Singapore, expanding its training program for aestheticians to 13 locations across 10 countries. This move emphasizes the company's growth strategy in the high-potential EMEA and APAC markets. The new centers will feature Syndeo, the next-gen delivery system, furthering Hydrafacial's international rollout in 2023. The HFX training program, introduced in 2018, enhances provider skills, driving increased usage of Hydrafacial machines among trained aestheticians.